NCT05612438 (RADIX 2) is a clinical trial of RADIX 2 Stent in Renal Artery Stenosis, sponsored by CID S.p.A..

Who is sponsoring NCT05612438?

NCT05612438 is sponsored by CID S.p.A..

What drugs are being tested in NCT05612438?

Interventions in NCT05612438: RADIX 2 Stent.

What condition does NCT05612438 study?

NCT05612438 studies Renal Artery Stenosis, Renal Failure.

Is NCT05612438 still recruiting?

NCT05612438 is currently status unknown. Last updated 10 November 2022.

Last reviewed 2022-11-10 · How we verify

NCT05612438: RADIX 2

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

RADIX 2 RENAL STENT Post-Market Retrospective Study

Status unknown Last updated 10 November 2022

What this trial tests

trial testing RADIX 2 Stent in Renal Artery Stenosis in 50 participants. Status unknown.

Timeline

3 March 2023

Primary endpoint
30 July 2023

30 August 2023

Quick facts

Lead sponsor	CID S.p.A.
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	3 March 2023
Primary completion	30 July 2023
Estimated completion	30 August 2023
Sites	1 location across Italy

Drugs / interventions tested

RADIX 2 Stent

Conditions studied

Renal Artery Stenosis — all drugs for Renal Artery Stenosis →
Renal Failure — all drugs for Renal Failure →

Sponsor

CID S.p.A.

Who can join

18 and older, any sex, with Renal Artery Stenosis or Renal Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Carbostent™ Radix 2 stent is a CE marked balloon expandable bare metal stent for the treatment of renal artery stenosis. The aim of this post-market retrospective study protocol P12204, is to collect clinical data on patients treated with the RADIX 2 stent in routine clinical practice. In order to obtain long-term follow-up data, the data collection will be limited to patients that have been treated with the Radix 2 stent at least 12 months prior to the study start.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Renal Artery Stenosis

Currently open trials in the same condition.

NCT06822205 — Identification and Treatment of Renal Stenosis in Transplanted Kidneys · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05612438 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by CID S.p.A.
Last refreshed: 10 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05612438.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing